Koska J, Migrino RQ, Chan KC, Cooper-Cox K, Reaven PD
Tirzepatide in the SURMOUNT trials showed even greater results, with some dose groups averaging over 20 percent body weight reduction
Tailored one anastomosis gastric bypass: 3-year outcomes of 94 patients
Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins
However, a recent meta-analysis of dual-energy X-ray absorptiometry-acquired body composition outcomes showed that approximately 30 % of the total weight loss achieved with GBT is attributed to lean mass loss [162], and a post hoc analysis of SURMOUNT-1 has reported that approximately 25 % of the weight loss in SURMOUNT-1 was due to lean body mass loss [163], thus suggesting that approximately 1 in 4 kg lost with GBT amounts to lean body mass loss
What Can Be Done: Proactive Steps for Optimizing Results At Revitalizing Health and Hormones, we recommend a few logical steps based on what the research is beginning to show: Before starting GLP-1 or peptide therapy, get a complete health and medication historyincluding cholesterol meds (statins), hormone levels, and metabolic labs